Novel BTNL3 and BTNL8 Variants in Familial Multiple Sclerosis Reveal a Potential γδ T-Cell Mechanism
Multiple sclerosis (MS) is a complex immune-mediated and neurodegenerative disorder of the central nervous system in which immune-mediated injury leads to demyelination, axonal damage, and progressive neurological dysfunction. Although most MS cases are considered complex and polygenic, familial clustering strongly suggests that, in some pedigrees, rare variants with larger biological effects may contribute substantially to disease risk. The article by Torabi-Rahvar and colleagues addresses this problem through the study of two multi-incident Iranian families with multiple affected relatives and a history of consanguinity, a design that is particularly useful for uncovering recessive or highly penetrant disease-associated variants. By combining whole-exome sequencing, segregation analysis, and in silico structural biology, the study aims to identify candidate loci that may illuminate previously unrecognized mechanisms in familial MS.
Study Design: A Family-Based Genomic Strategy
The investigators recruited familial MS cases from a clinically characterized Iranian cohort and selected two pedigrees with at least three affected individuals and inheritance patterns compatible with autosomal recessive transmission. Whole-exome sequencing was applied to affected and unaffected relatives, followed by variant filtering based on rarity, coding relevance, segregation pattern, and biological plausibility. When conventional analysis of single-nucleotide variants and small indels did not fully explain disease inheritance, the authors extended their analysis to copy number variants, which proved decisive in one family. This study design is notable because it recognizes that heritability in MS is unlikely to be explained by common alleles alone; rather, structural variation and rare coding alterations may account for part of the “missing heritability” that remains unresolved in autoimmune disease genetics.
Family 1: Identification of BTNL3 and BTNL8 Copy Number Variants
The most compelling result emerged in Family 1, where the authors identified co-segregating deletions involving the BTNL3 and BTNL8 genes. These deletions were homozygous in the affected sisters and heterozygous in their unaffected parents, consistent with autosomal recessive inheritance in that branch of the pedigree. Conventional PCR supported the absence of the targeted genomic regions in affected individuals, while haplotype analysis from exome data reinforced the segregation pattern. The study further notes that these deletions likely correspond to a previously described rearrangement that generates a BTNL8*3 fusion gene. Importantly, BTNL3 and BTNL8 encode immunoregulatory proteins of the butyrophilin-like family, molecules known to participate in epithelial immune homeostasis and in communication with γδ T cells. This makes them biologically credible candidates in a disease defined by immune dysregulation.
Mechanistic Interpretation: Disrupted γδ T-Cell Regulation
A major strength of the paper is that it does not stop at variant discovery. The authors model the structural consequences of the BTNL8*3 fusion protein and examine how this altered molecule might interact with the Vγ4 T-cell receptor. Under physiological conditions, BTNL3 and BTNL8 appear to form a heterodimer that contributes to T-cell receptor downregulation and maintenance of a restrained γδ T-cell state at epithelial barriers. The authors propose that the deletion-derived fusion protein weakens this regulatory interaction, potentially releasing γδ T cells from inhibitory control. In immunological terms, such a defect could enhance pro-inflammatory signaling, including pathways involving IL-17 and IFN-γ, both of which have long been implicated in MS-associated neuroinflammation. Thus, the study presents a plausible bridge between a rare inherited structural variant and a mechanism of pathological immune activation.
Structural Modeling and Linkage Evidence
The article strengthens its hypothesis through computational structural biology. Using AlphaFold-based modeling, SWISS-MODEL, HADDOCK docking, and PRODIGY affinity prediction, the authors show that the native BTNL8–BTNL3 complex and the deletion-derived BTNL83 fusion differ substantially in their interaction with the Vγ4Vδ1 T-cell receptor. The reported HADDOCK score for the BTNL8–BTNL3 complex was markedly more favorable than that of the BTNL83 fusion, and the predicted binding affinity was also weaker for the fusion construct, supporting the idea of impaired receptor engagement. In parallel, linkage analysis yielded a LOD score of 1.806, which the authors interpret as suggestive rather than definitive evidence. In the context of a small pedigree, this is a reasonable position: the score does not meet classical genome-wide linkage thresholds, but when viewed alongside perfect segregation in a sub-branch and strong biological plausibility, it provides meaningful support for BTNL3/BTNL8 as candidate loci in familial MS.
Family 2: A Rare MBL2 Variant as a Possible Modifier
In the second family, the genetic picture was more complex. After reanalysis, the researchers identified a rare homozygous missense variant in MBL2, p.Pro101Leu, in one affected individual. MBL2 encodes mannose-binding lectin, a key component of the lectin complement pathway and innate immune defense. Because the variant did not fully co-segregate with disease across all affected relatives, the authors appropriately refrain from labeling it as a primary causal mutation. Instead, they suggest that it may function as a genetic modifier within a broader multifactorial context. This is an important distinction. In familial autoimmune disease, not every rare variant in affected individuals is necessarily pathogenic on its own; some may influence penetrance, immune tone, or disease severity only in the presence of additional inherited or environmental factors. The MBL2 finding therefore illustrates the genetic heterogeneity of familial MS and the need for cautious interpretation of rare-variant data.
Scientific Significance, Limitations, and Future Directions
Overall, this study makes a valuable contribution by highlighting structural variation, especially BTNL3/BTNL8 deletions, as a potentially important and underexplored dimension of MS genetics. Its central message is that rare, family-specific variants affecting immune regulatory circuits may help explain disease susceptibility in selected pedigrees, particularly in genetically homogeneous populations. At the same time, the authors are careful to acknowledge the study’s limitations: the sample size is small, the findings are derived from only two families, and the proposed biological effects remain based largely on computational inference rather than direct functional validation. Future work should therefore include transcript studies, cytokine profiling, γδ T-cell activation assays, and replication in additional familial and population-based cohorts. Even with these caveats, the article offers a rigorous and conceptually important model for how genomics, segregation analysis, and structural immunology can be integrated to generate mechanistic hypotheses in complex neuroimmunological disease.
Disclaimer: This blog post is based on the provided research article and is intended for informational purposes only. It is not intended to provide medical advice. Please consult with a healthcare professional for any health concerns.
References:
Torabi-Rahvar, M., Talebi, S., Salehi, N. et al. Exome Sequencing and Molecular Modeling Reveal Novel Loci in Familial Multiple Sclerosis: The Importance of BTNL3 and BTNL8 in Disease Pathogenesis. Mol Neurobiol 63, 227 (2026). https://doi.org/10.1007/s12035-025-05436-w
